The Treatment Continuity Act of 2025 aims to improve the treatment of substance use disorders and serious mental illnesses in the United States. Its main purpose is to authorize the Secretary of Health and Human Services to enhance access to effective treatment options, specifically focusing on long-acting injectable medications. Key provisions of the Act include expanding the definition of treatment needs to include serious mental illness alongside substance use disorders.